DHGATE Founder Diane Wang Showcases New Motivational Book ‘The Inner Mountain’ in New Yorkby October 24, 2024PR Newswire
TOWER CAPITAL ASIA ANNOUNCES MAJORITY STAKE ACQUISITION IN KIZTOPIA – THE PREMIER FAMILY ENTERTAINMENT BUSINESSby October 24, 2024PR Newswire
TÜV Rheinland Supports 2024 Lenovo’s Supplier Standards and Certification Conference in China Advocating for Green Manufacturingby October 24, 2024PR Newswire
The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference Held in Chuxiong, Yunnan Provinceby October 24, 2024PR Newswire
Pearson and ServiceNow collaborate to supercharge workforce development and employee experiences in the age of AIby October 24, 2024PR Newswire
JinkoSolar Launches World’s Most Powerful Residential and Utility Solar Panels Tiger Neo 3.0by October 24, 2024PR Newswire
Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiativeby October 24, 2024PR Newswire
Fan-tastic Journeys: Sports and Music Events Take Fans to New Destinationsby October 24, 2024PR Newswire
Sports and Music Event Tourism unlocks new opportunities to capture spendby October 24, 2024PR Newswire
Boldyn Networks introduces Private 5G as a Service to drive digital transformationby October 24, 2024PR Newswire
Meiyume Debuts at Cosmopack Asia 2024: “Elevate: Reaching New Heights in Beauty Innovation”by October 24, 2024PR Newswire
Appier empowers Vietourist to transform lead generation and customer engagement with AI-driven solutionsby October 24, 2024PR Newswire
VFlowTech, MOL (Asia Oceania), and MOL PLUS Sign MoU for Strategic Collaboration on Long-Duration Energy Storage to Drive Sustainability in Southeast Asia’s Logistics and Maritime sectorby October 24, 2024PR Newswire
Appier ช่วย Vietourist ใช้โซลูชัน AI ยกระดับการหาลูกค้าและมีส่วนร่วมกับลูกค้าby October 24, 2024PR Newswire
Aker Horizons ASA: Invitation to presentation of third-quarter results 2024by October 24, 2024PR Newswire
Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterationsby October 24, 2024PR Newswire
